Cellectar Biosciences announces $10.0 million financing
Cellectar Biosciences announced it has entered into agreements with institutional investors to purchase $5.0 million in a registered direct offering of 1,982,000 common shares and $5.0 million in a concurrent private placement of 2,018,000 common shares. May 16, 2019